Winners of the Award will be selected by a jury featuring renowned international figures such as, Amartya Sen, Indian economist and Nobel laureate, Dr. Paul A. Sieving, Director of the National Eye Institute, and Susumu Tonegawa, distinguished immunologist and a Nobel laureate. Candidates will be judged on the quality and distinction of their initiatives, their achievements and the measurable impact of their work, and the enduring and amplifying effects of their activities.
To apply or nominate, please visit http://www.fchampalimaud.org/, a 2009 submission form is located under the Vision Award tab. Completed Entries must be received in full by the Foundation not later than December 31st, 2008.
About the Champalimaud Foundation
The Champalimaud Foundation supports individual researchers and
research teams working at the cutting edge of medical science. It aims to
stimulate novel theoretical and practical methodologies by utilizing the
experience of both research scientists and medical practitioners,
connecting pure scientific investigation with applied clinical research.
The Champalimaud Foundation aims to maximize the work being done in the
fields of cancer research and neuroscience, including stem cell research
and its clinical applications for Parkinson's and Alzheimer's disease,
diabetes and spinal injury. It is named for Antonio Champalimaud, who was
the richest man in Portugal when he died in 2004, bequeathing a quarter of
his $3.1 billion estate to set up the Foundation. See
http://www.fchampalimaud.or
'/>"/>
| SOURCE The Champalimaud Foundation Copyright©2008 PR Newswire. All rights reserved |